B
Biolight Life Sciences Ltd
TASE:BOLT
Biolight Life Sciences Ltd
TASE:BOLT
Price:
412 ILS
1.48%
Market Closed
Updated:
May 22, 2024
Section:
Relative Value
The Relative Value of one BOLT stock under the Base Case scenario is 20.34 ILS. Compared to the current market price of 412 ILS, Biolight Life Sciences Ltd is Overvalued by 95%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BOLT
Relative Value
Base Case
20.34
ILS
Overvaluation 95%
B
Valuation Multiples
Multiples Across Competitors
BOLT Competitors Multiples
Biolight Life Sciences Ltd Competitors
Biolight Life Sciences Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IL |
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
18.1m ILS | 153 | -0.7 | -0.9 | -0.9 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
224.3B USD | 5.3 | 37.2 | 23.2 | 33.8 | |
| US |
|
Danaher Corp
NYSE:DHR
|
197.4B USD | 4.5 | 24.5 | 17.7 | 21.9 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
45B USD | 6.7 | 36.4 | 29.1 | 35 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
41.5B USD | 2.8 | 30.5 | 16.6 | 25.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
55.4T KRW | 15 | 64.6 | 34.1 | 49.1 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37B CHF | 5.5 | 56.5 | 19.4 | 28.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
32.3B USD | 8.5 | 41.5 | 28.3 | 31.4 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
26.1B USD | 3.2 | 38.2 | 17.2 | 26.5 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
24.7B USD | 8.4 | 43.4 | 30.1 | 36.5 | |
| US |
|
Waters Corp
NYSE:WAT
|
20.8B USD | 7.2 | 34.5 | 23.1 | 28.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
